In Vitro Diagnostics (IVD) Quality Control Market exhibiting CAGR of 5.2% by 2032, owing to a rising number of accredited clinical laboratories | insightSLICE
The market for In Vitro Diagnostics (IVD) Quality Control was valued at US$ 1.1 billion in 2021 and is anticipated to increase at a CAGR of 5.2% through 2032.
In-vitro diagnostics (IVDs) are medical tools and supplies that are specially designed to enable in-vitro testing on bodily samples such as blood, tissues, and urine. They are widely used for the diagnosis and treatment of many medical conditions.
IVD quality controls are samples that are used to verify the reliability of the IVD testing system, ensure the accuracy of test results, and calculate the impact of variables like operator performance and ambient circumstances on test results.
Access the sample report: https://www.insightslice.com/request-sample/499
The key players of the Global In Vitro Diagnostics (IVD) Quality Control Market are:
Major companies involved in the global In Vitro Diagnostics (IVD) Quality Control Market include Alere, Inc., Abbott Laboratories, Inc., Becton, Bio-Rad Laboratories, Inc., bioMerieux, Inc., Dickinson, and Company (BD), Bio-Techne, Hologic, Inc. (Gen-Probe), Qiagen N.V., Quidel Corp., Roche Diagnostics, Thermo Fisher Scientific, Inc., Sero AS, Siemens Healthcare GmbH, and Sysmex Corp.
Driving factors for the growth of Global In Vitro Diagnostics (IVD) Quality Control Market
The existence of potential governing bodies and the growing number of authorized clinical labs worldwide are projected to be the key drivers of market expansion. Due to the huge prevalence of ailments including diabetes, cardiovascular diseases (CVDs), and infectious diseases, diagnostic laboratories are experiencing rapid improvement.
To meet industry standards, increase the volume of procedures, and draw in more patients, several public and private labs are completing laboratory accreditation procedures.
Read more about the report inclusions: https://www.insightslice.com/in-vitro-diagnostics-ivd-quality-control-market
Global In Vitro Diagnostics (IVD) Quality Control Market Key Segments:
By Application:
- Immunochemistry
- Hematology
- Clinical Chemistry
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
By Type:
- Quality control
- Quality assurance services
- Data management
By End Use:
- Hospitals
- Home healthcare
- Diagnostic Laboratories
- Others
By Geography:
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
The maximum growth rate is projected for the immunology application category:
In 2019, the immunology application segment held the largest market share. Understanding the function of the immune system involves studying its molecular mechanisms, which is what is known as immunology.
It primarily entails antigen action, antibody mechanism, and their exchanges. By identifying the presence of their coat and toxin antigens, contagious microbes including fungi, bacteria, and viruses can be identified, which is a significant use of immunochemistry.
The main drivers of the demand for immunochemistry techniques are the rise in epidemics of infectious and chronic diseases and the requirement for their initial detection.
Related reports:
Global Digital Dental Cameras Market: https://www.insightslice.com/digital-dental-cameras-market
Global Intelligent Hospital Beds Market: https://www.insightslice.com/intelligent-hospital-beds-market
Largest regional contributor is the USA:
The United States FDA, several reputable diagnostic labs, and robust QC regulatory frameworks made North America the largest regional market in 2019 and the area with the highest revenue share estimates.
The IVD QC market in North America is under the complete authority of the U.S. FDA and GHTF, from development to pre-and post-marketing evaluation.
Due to the region’s enormous potential for this market and the rising number of businesses that are engaged in product production, the APAC region is predicted to have the fastest rate of growth throughout the assessment.
The use of IVDs has also been promoted by the Asia Pacific Federation of Clinical Biochemistry and Laboratory Medicine. As a result, a greater awareness of the importance of an early, accurate diagnosis drives up product demand and, eventually, the IVD quality control market in the area.
Proceed to purchase: https://www.insightslice.com/buy-now/499
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
